Works matching IS 09697128 AND DT 2009 AND VI 16 AND IP 10

Results: 11

Progress and prospects: human artificial chromosomes.

Published in:

Gene Therapy, 2009, v. 16, n. 10, p. 1180, doi. 10.1038/gt.2009.102

By:

Macnab, S.;
Whitehouse, A.

Publication type:

Article

Transcriptional IL-15-directed in vivo DC targeting DNA vaccine.

Published in:

Gene Therapy, 2009, v. 16, n. 10, p. 1260, doi. 10.1038/gt.2009.110

By:

Tian, S.;
Liu, Z.;
Donahue, C.;
Noh, H. S.;
Falo, L. D.;
You, Z.

Publication type:

Article

Efficient, glucose responsive and islet-specific transgene expression by a modified rat insulin promoter.

Published in:

Gene Therapy, 2009, v. 16, n. 10, p. 1202, doi. 10.1038/gt.2009.114

By:

Chai, R.;
Chen, S.;
Ding, J.;
Grayburn, P. A.

Publication type:

Article

Lister strain of vaccinia virus armed with endostatin–angiostatin fusion gene as a novel therapeutic agent for human pancreatic cancer.

Published in:

Gene Therapy, 2009, v. 16, n. 10, p. 1223, doi. 10.1038/gt.2009.74

By:

Tysome, J. R.;
Briat, A.;
Alusi, G.;
Cao, F.;
Gao, D.;
Yu, J.;
Wang, P.;
Yang, S.;
Dong, Z.;
Wang, S.;
Deng, L.;
Francis, J.;
Timiryasova, T.;
Fodor, I.;
Lemoine, N. R.;
Wang, Y.

Publication type:

Article

An immobilized nanoparticle-based platform for efficient gene knockdown of targeted cells in the circulation.

Published in:

Gene Therapy, 2009, v. 16, n. 10, p. 1271, doi. 10.1038/gt.2009.76

By:

Huang, Z.;
King, M. R.

Publication type:

Article

CR1/2 is an important suppressor of Adenovirus-induced innate immune responses and is required for induction of neutralizing antibodies.

Published in:

Gene Therapy, 2009, v. 16, n. 10, p. 1245, doi. 10.1038/gt.2009.77

By:

Seregin, S. S.;
Aldhamen, Y. A.;
Appledorn, D. M.;
Schuldt, N. J.;
McBride, A. J.;
Bujold, M.;
Godbehere, S. S.;
Amalfitano, A.

Publication type:

Article

Immunological priming potentiates non-viral anti-inflammatory gene therapy treatment of neuropathic pain.

Published in:

Gene Therapy, 2009, v. 16, n. 10, p. 1210, doi. 10.1038/gt.2009.79

By:

Sloane, E.;
Langer, S.;
Jekich, B.;
Mahoney, J.;
Hughes, T.;
Frank, M.;
Seibert, W.;
Huberty, G.;
Coats, B.;
Harrison, J.;
Klinman, D.;
Poole, S.;
Maier, S.;
Johnson, K.;
Chavez, R.;
Watkins, L. R.;
Leinwand, L.;
Milligan, E.

Publication type:

Article

Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice.

Published in:

Gene Therapy, 2009, v. 16, n. 10, p. 1234, doi. 10.1038/gt.2009.80

By:

Hwang, D. H.;
Lee, H. J.;
Park, I. H.;
Seok, J. I.;
Kim, B. G.;
Joo, I. S.;
Kim, S. U.

Publication type:

Article

Engineering ligand-responsive gene-control elements: lessons learned from natural riboswitches.

Published in:

Gene Therapy, 2009, v. 16, n. 10, p. 1189, doi. 10.1038/gt.2009.81

By:

Link, K. H.;
Breaker, R. R.

Publication type:

Article

Stem cells, ribozymes and HIV.

Published in:

Gene Therapy, 2009, v. 16, n. 10, p. 1178, doi. 10.1038/gt.2009.86

By:

Burnett, J. C.;
Rossi, J. J.

Publication type:

Article

A fine balance: an autoregulatory gene therapy approach to treat obesity and achieve energy homeostasis.

Published in:

2009

By:

Samson, S. L.;
Kohjima, M.;
Chan, L.

Publication type:

Opinion